| Autor: |
Moscoso A; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden., Wren MC; Department of Imaging, Centre for Radiopharmaceutical Chemistry, University College London, London, UK.; Department of Chemistry, University College London, London, UK.; Queen Square Brain Bank for Neurological Disorders, Department of Clinical and Movement Neurosciences, Queen Square Institute of Neurology, University College London, London, UK.; Department of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London, London, UK., Lashley T; Queen Square Brain Bank for Neurological Disorders, Department of Clinical and Movement Neurosciences, Queen Square Institute of Neurology, University College London, London, UK.; Department of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London, London, UK., Arstad E; Department of Imaging, Centre for Radiopharmaceutical Chemistry, University College London, London, UK.; Department of Chemistry, University College London, London, UK., Murray ME; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA., Fox NC; Dementia Research Centre, Department of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London, London, UK.; UK Dementia Research Institute, Queen Square Institute of Neurology, University College London, London, UK., Sander K; Department of Imaging, Centre for Radiopharmaceutical Chemistry, University College London, London, UK.; Department of Chemistry, University College London, London, UK., Schöll M; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. michael.scholl@neuro.gu.se.; Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden. michael.scholl@neuro.gu.se.; Dementia Research Centre, Department of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London, London, UK. michael.scholl@neuro.gu.se.; Department of Clinical Physiology, Sahlgrenska University Hospital, Röda stråket 10B, 413 45, Gothenburg, Sweden. michael.scholl@neuro.gu.se. |
